摘要
目的了解1993~1995年度临床使用的新鲜冰冻血浆(FFP)和血液制品中艾滋病毒(HIV)、丙肝病毒(HCV)的感染情况。方法用ELISA、WB和PCR对110批FFP、人血丙种球蛋白、人血白蛋白检测了抗HCV、HCVRNA、抗HIV(1+2)、HIV-1RNA。结果所有血制品抗HCV的平均阳性率为19.1%,HCVRNA为17.3%;1993~1994年度FFP的抗HCVHCVRNA阳性率比1995年度高(30%、26%和0.5%);人血丙球的抗HCV和HCVRNA阳性率明显高于人血白蛋白(30%、20%和0.5%);89批抗HCV阴性血制品HCVRNA的阳性率为5.6%,所有血制品的抗HIV(1+2)和HIV-1RNA均阴性。结论1993~1995年度临床上所使用的血制品,特别是1993~1994年度的FFP,有传播HCV的危险,这与当时没有对所有供血者进行抗HCV筛检有关。
OBJECTIVE To evaluate the risk of HCV and HIV infection from fresh frozen plasma (FFP) and plasma derivatives used in clinical during 1993~1995 were studied. METHODS 110 batches of FFP, human immunoglobulin and human serum albumin were detected for anti-HCV, HCV RNA, anti-HIV (1+2) 、HIV-1RNA by ELISA, western blot (WB) and PCR. RESULTS For all the plasma products, the average positive rate of anti-HCV was 19.1%, and HCV RNA 17.3%. The positive rates of anti-HCV and HCV RNA in FFP from 1993 to 1994 were higher than that in 1995 (30%, 26% and 0.5% respectively, P 1<0.01, P 2<0.05). The positive rates of anti-HCV and HCV RNA in human immunoglobulin were obviously higher than that in human serum albumin (30%, 20% and 0.5% respectively, P 1<0.01, P 2>0.05). For 89 batches of anti-HCV negative plasma products, the positive rate of HCV RNA was 5.6%. All plasma products detected were anti-HIV (1+2) and HIV-1RNA negative except one batch of human immunoglobulin was anti-HIV (1+2) positive in sereening test, but negative in WB confirmatory test. CONCLUSION THe results suggested that the plasma products used in clinical during 1993~1995, especially the FFP from 1993 to 1994, were not always safe. This risk was associated with that not all donors had been screened for anti-HCV then.
出处
《中华医院感染学杂志》
CAS
CSCD
1999年第1期1-3,共3页
Chinese Journal of Nosocomiology
关键词
血液制品
HCV
艾滋病
检测
Plasma derivatives HCVAb HCV-RNA Anti-HIV/ (1+2) HIV-IRNA